25 May 2013
Keywords: Lundbeck, PAION, Desmoteplase, Ischemic stroke, Licensing
Article | 18 October 2010
Aachen, Germany-based biopharmaceutical company PAION AG (FSE: PA8) has expanded its desmoteplase licence deal with existing partner Denmark’s ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 October 2010
24 May 2013
© 2013 thepharmaletter.com